Paksiree Saranaruk

The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.

K. Sawanyawisuth, C. Wongkham, S. Wongkham, 2019, Glycobiology.

Five-(Tetradecyloxy)-2-furoic Acid Alleviates Cholangiocarcinoma Growth by Inhibition of Cell-cycle Progression and Induction of Apoptosis

R. Kariya, S. Okada, K. Sawanyawisuth, 2021, AntiCancer Research.

Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients

S. Okada, K. Sawanyawisuth, C. Wongkham, 2023, PeerJ.

Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1-related anti-apoptotic proteins

T. Boonmars, R. Kariya, S. Okada, 2020, International journal of molecular medicine.

Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma

S. Wongkham, U. Cha'on, Wunchana Seubwai, 2021, In Vivo.

Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor

S. Okada, S. Obchoei, S. Wongkham, 2022, Asian Pacific journal of cancer prevention : APJCP.